Sign In
Buy TMO
$473.95
-8.13 (-1.69%)
At Close: Jun 03, 2026
Thermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty
12:05pm, Wednesday, 23'rd Apr 2025
Thermo Fisher Scientific Inc. TMO reported first-quarter 2025 adjusted earnings per share of $5.15 on Wednesday, beating the street view of $5.10.
Thermo Fisher Tops Q1 Estimates in 'Uncertain Macroeconomic Environment'
11:26am, Wednesday, 23'rd Apr 2025
Thermo Fisher Scientific (TMO) shares rose Wednesday after the lab equipment and life science solutions firm reported first-quarter results above analysts' expectations.
Thermo Fisher Scientific Inc. (TMO) Q1 2025 Earnings Call Transcript
11:16am, Wednesday, 23'rd Apr 2025
Thermo Fisher Scientific Inc. (NYSE:TMO ) Q1 2025 Earnings Conference Call April 23, 2025 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, Pre
Thermo Fisher (TMO) Reports Q1 Earnings: What Key Metrics Have to Say
10:35am, Wednesday, 23'rd Apr 2025
While the top- and bottom-line numbers for Thermo Fisher (TMO) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics comp
Thermo Fisher Scientific (TMO) Q1 Earnings and Revenues Beat Estimates
08:10am, Wednesday, 23'rd Apr 2025
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.15 per share, beating the Zacks Consensus Estimate of $5.10 per share. This compares to earnings of $5.11 per share a year ago.
Buckle Up Buttercup - Here's What Every (Dividend) Investor Needs To Hear Right Now
07:30am, Wednesday, 23'rd Apr 2025
Trade uncertainty, Fed drama, and stretched valuations are driving a powerful capital rotation away from U.S. assets, impacting the dollar, debt, and equities. Despite headwinds, I remain confident in
Thermo Fisher beats estimates on steady demand for tools and services used in clinical research
07:19am, Wednesday, 23'rd Apr 2025
Thermo Fisher Scientific reported better-than-expected profit and revenue for the first quarter on Wednesday, helped by resilient demand for its products and services used for developing therapies.
Thermo Fisher Scientific Reports First Quarter 2025 Results
06:00am, Wednesday, 23'rd Apr 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 29, 2025. First
2 Of The Biggest Dip Opportunities In Dividend (Growth) Land
07:30am, Sunday, 20'th Apr 2025
Market fear creates hesitation, but history shows scary headlines often mark great buying opportunities. I assess risk, not just wait for perfect timing. My strategy to rotate from growth to value has
Stay Ahead of the Game With Thermo Fisher (TMO) Q1 Earnings: Wall Street's Insights on Key Metrics
10:21am, Thursday, 17'th Apr 2025
Get a deeper insight into the potential performance of Thermo Fisher (TMO) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for
Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Greater San Diego to Help Accelerate Cell Therapy Development
08:30am, Thursday, 17'th Apr 2025
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC) in Carls
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for
11:06am, Wednesday, 16'th Apr 2025
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings
08:35am, Wednesday, 16'th Apr 2025
Strength in Analytical Instruments and Specialty Diagnostics segments is likely to have driven Thermo Fisher's first-quarter 2025 performance.
Thermo Fisher Scientific And Its Real Value
11:27am, Monday, 14'th Apr 2025
Thermo Fisher Scientific shows strong fundamentals, consistent earnings growth, and solid financial health, making it a viable long-term investment. TMO's recent product expansion, including the break
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the 5L DynaDrive Single-Use Bioreactor (S.U.B.), designed to meet the evolving need
